303
Views
1
CrossRef citations to date
0
Altmetric
Papers

Genetic contributing factors to substance abuse: an association study between eNOS gene polymorphisms and cannabis addiction in a Turkish population

, , , &
Pages 676-683 | Received 24 Jul 2015, Accepted 16 Oct 2015, Published online: 14 Dec 2015

References

  • Lachman HM. An overview of the genetics of substance use disorders. Curr. Psychiatry Rep. 2006;8:133–143.10.1007/s11920-006-0013-3
  • Agrawal A, Verweij KJH, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, Nelson EC, Slutske WS, Whitfield JB, Lynskey MT. The genetics of addiction - a translational perspective. Transl Psychiatry. 2012;2:e140.10.1038/tp.2012.54
  • Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction. 2009;104:518–532.10.1111/add.2009.104.issue-4
  • Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafo MR, Tyndale RF. Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther. 2010;88:779–791.10.1038/clpt.2010.175
  • MacKillop J. Integrating behavioral economics and behavioral genetics: delayed reward discounting as an endophenotype for addictive disorders. J Exp Anal Behav. 2013;99:14–31.10.1002/jeab.v99.1
  • Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet. 2005;6:521–532.10.1038/nrg1635
  • Jain R, Balhara YP. Neurobiology of cannabis addiction. Indian J Physiol Pharmacol. 2008;52:217–232.
  • Lonart G, Cassels KL, Johnson KM. Nitric oxide induces calcium-dependent release of [3H] dopamine release from striatal slices. J Neurosci Res. 1993;35:192–198.10.1002/(ISSN)1097-4547
  • Lorrain DS, Hull EM. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport. 1993;5:87–89.10.1097/00001756-199310000-00024
  • Lorrain DS, Matuszewich L, Howard RV, Du J, Hull EM. Nitric oxide promotes medial preoptic dopamine release during male rat copulation. Neuroreport. 1996;8:31–34.10.1097/00001756-199612200-00007
  • Zhu XZ, Luo LG. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem. 1992;59:932–935.10.1111/jnc.1992.59.issue-3
  • Nath SD, He X, Voruganti VS, Blangero J, MacCluer JW, Comuzzie AG, Arar NH, Abboud HE, Thameem F. The 27-bp repeat polymorphism in intron 4 (27 bp-VNTR) of endothelial nitric oxide synthase (eNOS) gene is associated with albumin to creatinine ratio in Mexican Americans. Mol Cell Biochem. 2009;331:201–205.10.1007/s11010-009-0159-5
  • Demas GE, Kriegsfeld LJ, Blackshaw S, Huang P, Gammie SC, Nelson RJ, Snyder SH (1999) Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci 19:RC30.
  • Rujescu D, Giegling I, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, Möller HJ, Serretti A (2008) NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet 5(147B1):42–48.10.1002/(ISSN)1552-485X
  • Frisch C, Dere E, Silva MA, Godecke A, Schrader J, Huston JP. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci. 2000;20:6694–6700.
  • Wang XL, Mahaney MC, Sim AS, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17:3147–3153.10.1161/01.ATV.17.11.3147
  • Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Iqari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190–193.10.1006/bbrc.1998.8267
  • Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synhase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;97:2832–2835.10.1073/pnas.97.6.2832
  • Guzik TJ, Black E, West NE, McDonald D, Ratnatunga C, Pillai R, Channon KM. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J of Med Genet. 2001;100:130–137.10.1002/(ISSN)1096-8628
  • Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002;20:2023–2027.10.1097/00004872-200210000-00022
  • Fujita S, Masago K, Hatachi Y, Fukuhara A, Hata A, Kaji R, Kim YH, Mio T, Mishima M, Katakami N. Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy. BMC Med Genet. 2010;11:167.10.1186/1471-2350-11-167
  • da Silva RF, Sertório JTC, Lacchini R, Trapé AA, Tanus-Santos JE, Rush JWE, Amaral SL, Zago AS. Influence of training status and eNOS haplotypes on plasma nitrite concentrations in normotensive older adults: a hypothesis-generating study. Aging Clin Exp Res. 2014;26:591–598.10.1007/s40520-014-0218-y
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: The American Psychiatric Association; 1994.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.10.1093/nar/16.3.1215
  • Erciyas K, Pehlivan S, Sever T, Igci M, Pehlivan M, Arslan A, Orbak R. Endothelial nitric oxide synthase gene polymorphisms associated with periodontal diseases in Turkish adults. African J of Biotec. 2010;9:3042–3047.
  • Salum C, Bermudez-Echeverry M, Issy AC, Del-Bel EA. Dopamine system and its modulation by nitric oxide: approaches in experimental Parkinson and schizophrenia. In: Watanabe A (ed) A Dopamine Research Advances. New York, NY: Nova Science Publishers, Inc; 2008; 153–191.
  • Isir AB, Oguzkan S, Nacak M, Gorucu S, Dulger HE, Arslan A. The catechol-O-methyl transferase val158met polymorphism and susceptibility to cannabis dependence. Am J Foren Med Path. 2008;29:320–322.10.1097/PAF.0b013e3181847e56
  • Nacak M, Isir AB, Balci SO, Pehlivan S, Benlier N, Aynacioglu S. Analysis of dopamine d2 receptor (drd2) gene polymorphisms in cannabinoid addicts. J Forensic Sci. 2012;57:1621–1624.10.1111/j.1556-4029.2012.02169.x
  • Isir AB, Nacak M, Balci SO, Pehlivan S, Kul S, Benlier N, Aynacioglu AS. Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population. Aust J Forensic Sci. 2014;47:230–238.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.